Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.58 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.58 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.58 |
| ▸ | EGFR | P00533 | 1/20 | 0.31 |
| ▸ | SRC | P12931 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7201113 | 0.96 | LMNA (0.61) | LMNACYP2C19HIF1AEGFRSRC | |
| SCHEMBL7795950 | 0.92 | LMNA (0.59) | LMNACYP2C19HIF1AEGFRSRC | |
| SCHEMBL7986036 | 0.90 | LMNA (0.57) | LMNACYP2C19HIF1AEGFRSRC | |
| SCHEMBL9236621 | 0.87 | LMNA (0.59) | LMNACYP2C19HIF1AEGFRSRC | |
| SCHEMBL9756265 | 0.87 | LMNA (0.56) | LMNACYP2C19HIF1AEGFRSRC | |
| Ioversol SCHEMBL24711 | 0.87 | LMNA (0.64) | LMNACYP2C19HIF1AEGFRSRC | |
| Ioversol SCHEMBL9745016 | 0.87 | LMNA (0.64) | LMNACYP2C19HIF1AEGFRSRC | |
| SCHEMBL8438095 | 0.87 | LMNA (0.64) | LMNACYP2C19HIF1AEGFRSRC | |
| SCHEMBL9009203 | 0.86 | CYP2C19 (0.73) | LMNACYP2C19HIF1AEGFRSRC | |
| SCHEMBL5033214 | 0.85 | LMNA (0.61) | LMNACYP2C19HIF1AEGFRSRC |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0839056-A4 | PROCESS FOR PRODUCING IOVERSOL | MALLINCKRODT MEDICAL INC (US) | 2000-09-13 | — | — | EP | disclosed |
| EP-0886634-A4 | PROCESS FOR PRODUCING IOVERSOL | MALLINCKRODT MEDICAL INC (US) | 2000-08-02 | — | — | EP | disclosed |
| EP-0886634-A1 | PROCESS FOR PRODUCING IOVERSOL | MALLINCKRODT MEDICAL, INC. (US) | 1998-12-30 | — | — | EP | disclosed |
| EP-0839056-A1 | PROCESS FOR PRODUCING IOVERSOL | MALLINCKRODT MEDICAL, INC. (US) | 1998-05-06 | — | — | EP | disclosed |
| WO-1997027172-A1 | PROCESS FOR PRODUCING IOVERSOL | MALLINCKRODT MEDICAL, INC. (US) | 1997-07-31 | — | — | WO | disclosed |
| WO-1996040286-A1 | PROCESS FOR PRODUCING IOVERSOL | MALLINCKRODT MEDICAL, INC. (US) | 1996-12-19 | — | — | WO | disclosed |
| EP-0628024-A4 | SYNTHESIS OF IOVERSOL USING A MINIMAL EXCESS OF ACETOXYACETYLCHLORIDE. | MALLINCKRODT MEDICAL INC (US) | 1995-03-22 | — | — | EP | disclosed |
| EP-0628024-A1 | SYNTHESIS OF IOVERSOL USING A MINIMAL EXCESS OF ACETOXYACETYLCHLORIDE | MALLINCKRODT MEDICAL, INC. (US) | 1994-12-14 | — | — | EP | disclosed |
| EP-0598751-A1 | SYNTHESIS OF IOVERSOL USING CHLOROACETYL CHLORIDE | MALLINCKRODT MEDICAL, INC. (US) | 1994-06-01 | — | — | EP | disclosed |
| WO-1993016981-A1 | SYNTHESIS OF IOVERSOL USING A MINIMAL EXCESS OF ACETOXYACETYLCHLORIDE | MALLINCKRODT MEDICAL, INC. (US) | 1993-09-02 | — | — | WO | disclosed |
| WO-1993001840-A1 | SYNTHESIS OF IOVERSOL USING CHLOROACETYL CHLORIDE | MALLINCKRODT MEDICAL, INC. (US) | 1993-02-04 | — | — | WO | disclosed |
| EP-0083964-A1 | Compounds suitable for X-ray visualisation methods | Mallinckrodt, Inc. (a Delaware corporation) (US) | 1983-07-20 | — | — | EP | disclosed |